Jack D. Schim

Neurology
6010 Hidden Valley Rd
Carlsbad, CA 92011

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial.

Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial.

Journal: Headache
Published: December 20, 2023

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.

Journal: The journal of headache and pain
Published: June 23, 2022

Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlled randomized clinical trials.

Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlled randomized clinical trials.

Journal: Headache
Published: October 18, 2021

Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study.

Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study.

Journal: Pain reports
Published: May 18, 2021

Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers.

Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers.

Journal: Neurology and therapy
Published: February 05, 2021

Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review.

Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review.

Journal: Pain and therapy
Published: December 18, 2020

Moving the Needle, the Clinical Perspective.

Moving the Needle, the Clinical Perspective.

Journal: Headache
Published: April 20, 2020

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.

Journal: The journal of headache and pain
Published: May 02, 2019

Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative review.

Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative review.

Journal: Headache
Published: May 02, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026